Jane Street
IOVA icon

Jane Street’s Iovance Biotherapeutics IOVA Stock Holding History

Jane Street’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$798K Buy
227,300
+104,500
+85% +$334K ﹤0.01% 6981
2025
Q4 		$335K Buy
122,800
+54,300
+79% +$126K ﹤0.01% 8584
2025
Q3 		$149K Buy
68,500
+2,200
+3% +$5.2K ﹤0.01% 9887
2025
Q2 		$114K Buy
66,300
+6,000
+10% +$14.9K ﹤0.01% 8896
2025
Q1 		$201K Sell
60,300
-175,500
-74% -$905K ﹤0.01% 8444
2024
Q4 		$1.74M Buy
235,800
+93,700
+66% +$869K ﹤0.01% 4359
2024
Q3 		$1.33M Buy
142,100
+77,200
+119% +$731K ﹤0.01% 5293
2024
Q2 		$520K Sell
64,900
-2,300
-3% -$24.6K ﹤0.01% 6956
2024
Q1 		$996K Sell
67,200
-91,100
-58% -$1.06M ﹤0.01% 5422
2023
Q4 		$1.29M Sell
158,300
-564,600
-78% -$2.95M ﹤0.01% 5119
2023
Q3 		$3.29M Buy
722,900
+658,200
+1,017% +$4.3M ﹤0.01% 3224
2023
Q2 		$455K Buy
64,700
+23,200
+56% +$166K ﹤0.01% 6452
2023
Q1 		$254K Buy
41,500
+12,300
+42% +$84.9K ﹤0.01% 7464
2022
Q4 		$187K Sell
29,200
-21,500
-42% -$168K ﹤0.01% 7719
2022
Q3 		$486K Sell
50,700
-520,400
-91% -$6M ﹤0.01% 6745
2022
Q2 		$6.3M Buy
571,100
+497,900
+680% +$6.52M ﹤0.01% 2330
2022
Q1 		$1.22M Buy
73,200
+2,300
+3% +$35.6K ﹤0.01% 5727
2021
Q4 		$1.35M Sell
70,900
-54,700
-44% -$1.2M ﹤0.01% 5298
2021
Q3 		$3.1M Sell
125,600
-142,900
-53% -$3.37M ﹤0.01% 3589
2021
Q2 		$6.99M Buy
268,500
+236,200
+731% +$6.14M ﹤0.01% 2168
2021
Q1 		$1.02M Sell
32,300
-40,600
-56% -$1.68M ﹤0.01% 5407
2020
Q4 		$3.38M Buy
72,900
+5,500
+8% +$218K ﹤0.01% 2652
2020
Q3 		$2.22M Buy
67,400
+3,200
+5% +$98.1K ﹤0.01% 2874
2020
Q2 		$1.76M Buy
64,200
+38,800
+153% +$1.28M ﹤0.01% 3238
2020
Q1 		$761K Buy
+25,400
New +$673K ﹤0.01% 3132

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Jane Street's IOVA Position: Q1 2026 in Review

Jane Street increased its Iovance Biotherapeutics (IOVA) stake by 16% in Q1 2026, buying an estimated $1.89M and bringing the position to 4,173,886 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

Jane Street first reported a position in IOVA in Q3 2017 and has held it in 29 quarters since. The position peaked at $15.1M in Q1 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Jane Street held 4,173,886 shares of Iovance Biotherapeutics worth $14.7M as of Q1 2026.
  • Jane Street bought 590,076 Iovance Biotherapeutics shares in Q1 2026, an estimated $1.89M.
  • Iovance Biotherapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2089 holding.
  • Jane Street first reported a position in Iovance Biotherapeutics in Q3 2017 and has held it in 29 quarters since.
  • Jane Street's Iovance Biotherapeutics position peaked at $15.1M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.